INTRODUCTION: Magnetocardiographic (MCG) mapping is a new method to record cardiac signals. This study examined the association of MCG late fields with the propensity to sustained ventricular tachycardia (VT) after myocardial infarction (MI). METHODS AND RESULTS: One hundred patients with remote MI were studied, 38 with and 62 without history of VT. High-resolution MCG and signal-averaged ECG (SAECG) as a comparative method were recorded. Time-domain parameters describing the abnormal low-amplitude end QRS activity, MCG late fields, and SAECG late potentials were analyzed. Late field parameters differed significantly between the patient groups: filtered QRS duration was 137 +/- 26 msec in the VT group and 110 +/- 18 msec in the control group (P < 0.001), and root mean square amplitude of the last 40 msec was 260 +/- 170 and 510 +/- 360 fT (P < 0.001), respectively. The optimal MCG parameter combination yielded a sensitivity of 92% and a specificity of 61% in classification to the VT group, whereas those for SAECG were 63% and 66%. In a subgroup of 63 patients with marked left ventricular dysfunction and comparable stage of coronary heart disease, only MCG (sensitivity 73%, specificity 67%) but not SAECG could assign a patient to the VT group. CONCLUSION: Late fields of the MCG QRS complex indicate propensity to life-threatening arrhythmias in post-MI patients. This discriminative ability persists in the presence of severe left ventricular dysfunction where ECG late potentials lose their informative value. MCG late field analysis is a potential new method for noninvasive risk assessment in post-MI patients.
INTRODUCTION: Magnetocardiographic (MCG) mapping is a new method to record cardiac signals. This study examined the association of MCG late fields with the propensity to sustained ventricular tachycardia (VT) after myocardial infarction (MI). METHODS AND RESULTS: One hundred patients with remote MI were studied, 38 with and 62 without history of VT. High-resolution MCG and signal-averaged ECG (SAECG) as a comparative method were recorded. Time-domain parameters describing the abnormal low-amplitude end QRS activity, MCG late fields, and SAECG late potentials were analyzed. Late field parameters differed significantly between the patient groups: filtered QRS duration was 137 +/- 26 msec in the VT group and 110 +/- 18 msec in the control group (P < 0.001), and root mean square amplitude of the last 40 msec was 260 +/- 170 and 510 +/- 360 fT (P < 0.001), respectively. The optimal MCG parameter combination yielded a sensitivity of 92% and a specificity of 61% in classification to the VT group, whereas those for SAECG were 63% and 66%. In a subgroup of 63 patients with marked left ventricular dysfunction and comparable stage of coronary heart disease, only MCG (sensitivity 73%, specificity 67%) but not SAECG could assign a patient to the VT group. CONCLUSION: Late fields of the MCG QRS complex indicate propensity to life-threatening arrhythmias in post-MI patients. This discriminative ability persists in the presence of severe left ventricular dysfunction where ECG late potentials lose their informative value. MCG late field analysis is a potential new method for noninvasive risk assessment in post-MI patients.
Authors: Bei Wang; Petri Korhonen; Ilkka Tierala; Helena Hänninen; Heikki Väänänen; Lauri Toivonen Journal: Ann Noninvasive Electrocardiol Date: 2013-07-30 Impact factor: 1.468
Authors: Petri Korhonen; Ilkka Tierala; Kim Simelius; Heikki Väänänen; Markku Mäkijärvi; Jukka Nenonen; Toivo Katila; Lauri Toivonen Journal: Ann Noninvasive Electrocardiol Date: 2002-10 Impact factor: 1.468
Authors: A Kandori; H Kanzaki; K Miyatake; S Hashimoto; S Itoh; N Tanaka; T Miyashita; K Tsukada Journal: Med Biol Eng Comput Date: 2001-01 Impact factor: 2.602
Authors: Paula Vesterinen; Helena Hänninen; Milla Karvonen; Kirsi Lauerma; Miia Holmström; Markku Mäkijärvi; Heikki Väänänen; Jukka Nenonen; Toivo Katila; Lauri Toivonen Journal: Ann Noninvasive Electrocardiol Date: 2004-07 Impact factor: 1.468
Authors: Raija Jurkko; Heikki Väänänen; Ville Mäntynen; Jouni Kuusisto; Markku Mäkijärvi; Lauri Toivonen Journal: Ann Noninvasive Electrocardiol Date: 2008-10 Impact factor: 1.468